The tenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders addresses issues related to the safety and supply of treatment products for bleeding disorders, and brings together patient groups, regulators, representatives from industry, and not-for-profit fractionators, as well as doctors who treat people with bleeding disorders.
Sessions from the 10th WFH Global Forum will cover the latest developments in treatment and research including:
- An update on plasma-derived product transfusion transmitted infection risks
- Prevention of inhibitors
- Data on the outcomes of extended half-life products
- How will we afford new biological medicines?
- Unmet needs and unfinished business in gene therapy
- WFH research projects: epidemiology and the World Bleeding Disorders Registry